TIMOTHY HAINES: Open Payments
NPI 1699144170 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 15 payments from 9 companies in 2025. Trend: 2023 $442 · 2024 $658 · 2025 $451
Food & beverage: $373Education: $78
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $108 |
| Insmed, Inc. | 2 | $65 |
| Gilead Sciences, Inc. | 2 | $65 |
| ViiV Healthcare Company | 2 | $59 |
| Ferring Pharmaceuticals Inc. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 1 | $33 |
| Shionogi Inc | 1 | $31 |
| Cumberland Pharmaceuticals, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
Products named: Arikayce, REBYOTA, DOVATO, VOWST, Fetroja, Cresemba, CABENUVA, VIBATIV.
Industry payments across SC — which companies pay providers there.
